Skip to main content

Atrial Fibrillation-Bristol-Myers Squibb (AUGUSTUS)

The purpose of this study is to evaluate the capabilities in decreasing blood clots and bleeding events in patients with atrial fibrillation or acute coronary syndrome or in patients who have had previous heart surgery.

Sponsor: Bristol-Myers Squibb

Phase: 4

Indicators: Atrial Fibrillation or Acute Coronary Syndrome or Percutaneous Coronary Intervention

Age: 18 years or older

Category: Interventional

For more information :https://clinicaltrials.gov/ct2/show/NCT02415400

 

Studies Currently Available At

Sign Up For This Study